BEDFORD, Mass., Feb. 22, 2018 /PRNewswire/ — Access Vascular, a medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its lead product, the HydroPICC™, a peripherally inserted central catheter, […]
Radiology
Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
SAN FRANCISCO, Feb. 15, 2018 /PRNewswire/ — Arterys Inc., the leader in intelligent, cloud-based medical imaging software solutions, today announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance is for the Arterys Oncology AI suite, and is a milestone indicative of the company’s momentum in applying AI […]
BD Completes Asset Divestitures to Merit Medical
FRANKLIN LAKES, N.J., Feb. 15, 2018 /PRNewswire/ — Becton, Dickinson and Company (NYSE: BDX), a leading global medical technology company, announced today that it has completed the previously announced divestitures of its soft tissue core needle biopsy product line and Aspira® product line to Merit Medical Systems, Inc. following receipt of all required […]
ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors
New Directors Bring Extensive Medical Device Experience to the Board [07-February-2018] CLEVELAND, Feb. 7, 2018 /PRNewswire/ — ViewRay (Nasdaq: VRAY), maker of the world’s first and only clinical MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Huennekens and Daniel Moore to the Company’s board of directors, […]
Varian to Discuss Agreement to Acquire Sirtex
PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ — Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical. Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is […]
Surefire Medical Names Former Novelion CEO as New Leader
DENVER–(BUSINESS WIRE)– Surefire Medical (Surefire) today announced the appointment of Mary T. Szela as its CEO, President, and a member of the company’s Board of Directors. Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and pharmaceutical industries, […]
Bluegrass Vascular Announces Enrollment of First Patients in U.S. Pivotal Trial
SAN ANTONIO, Jan. 18, 2018 /PRNewswire/ — Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its first patients in the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial. The SAVE-US clinical trial is a pre-market […]
Beverly A. Huss Joins Accuray Board of Directors
SUNNYVALE, Calif., Jan. 11, 2018 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company’s Board of Directors, effective January 7, 2018. Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc., Surefire Medical, Inc., and Madorra. Her prior public company board experience includes Artes Medical, Wright […]
Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology
Villepinte (France), January 8, 2018 (17:45 CET) – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical Therapeutics (“Accurate”), which specializes in the development of microcatheters used in […]
Teleflex Surpasses 200,000 Successfully Reprocessed ClosureFast® Catheters
WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast® Catheters have been successfully reprocessed by the company’s partner, Northeast Scientific, Inc. (NES), since NES received FDA clearance for reprocessing the popular vein ablation catheter in 2011. […]